Home » Topics » BioWorld Science

BioWorld Science
RSS

Onco TCS slated to enter phase II

May 3, 1996

AG-2034 data reported at AACR

May 3, 1996

Matrix presents improved formulation of vinblastine

May 3, 1996

Antitumor nucleosides disclosed by Yamasa Shoyu

May 3, 1996

Positive results obtained in AllerVax Cat trial

May 3, 1996

HemispheRx, Helix will codevelop nucleic acid compounds

May 3, 1996

ALT expected to receive streamlined review at FDA

May 3, 1996

Centeon to codevelop Medarex's MDX-33

May 3, 1996

Fujisawa reports collagenase inhibitors

May 3, 1996

New immunosuppressants from Shionogi

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.